MORC2
Basic information
Region (hg38): 22:30925130-30968774
Previous symbols: [ "ZCWCC1" ]
Links
Phenotypes
GenCC
Source:
- Charcot-Marie-Tooth disease axonal type 2Z (Supportive), mode of inheritance: AD
- Charcot-Marie-Tooth disease axonal type 2Z (Strong), mode of inheritance: AD
- developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (Strong), mode of inheritance: AD
- Leigh syndrome (Limited), mode of inheritance: AD
- Charcot-Marie-Tooth disease axonal type 2Z (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Charcot-Marie-Tooth disease type, axonal, type 2Z; Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 26497905; 27105897; 28771897; 32693025 |
ClinVar
This is a list of variants' phenotypes submitted to
- Charcot-Marie-Tooth disease axonal type 2Z (8 variants)
- not provided (3 variants)
- Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (3 variants)
- Charcot-Marie-Tooth disease (2 variants)
- Inborn genetic diseases (2 variants)
- Global developmental delay (1 variants)
- MORC2-related disorder (1 variants)
- Neurodevelopmental disorder (1 variants)
- MORC2-related neurodevelopmental disorders (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MORC2 gene is commonly pathogenic or not. These statistics are base on trasncript: . Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 162 | 11 | 179 | |||
missense | 10 | 18 | 343 | 13 | 384 | |
nonsense | 10 | 10 | ||||
start loss | 1 | 1 | ||||
frameshift | 7 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
Total | 10 | 18 | 374 | 175 | 11 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MORC2 | protein_coding | protein_coding | ENST00000215862 | 23 | 43168 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000144 | 125739 | 0 | 9 | 125748 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.23 | 376 | 598 | 0.629 | 0.0000374 | 6328 |
Missense in Polyphen | 59 | 154.44 | 0.38203 | 1825 | ||
Synonymous | 0.959 | 203 | 221 | 0.918 | 0.0000129 | 1903 |
Loss of Function | 6.31 | 6 | 57.8 | 0.104 | 0.00000335 | 625 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000867 | 0.0000867 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000886 | 0.00000879 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Exhibits a cytosolic function in lipogenesis, adipogenic differentiation, and lipid homeostasis by increasing the activity of ACLY, possibly preventing its dephosphorylation (PubMed:24286864). May act as a transcriptional repressor (PubMed:20225202). Down-regulates CA9 expression (PubMed:20110259). {ECO:0000269|PubMed:20110259, ECO:0000269|PubMed:20225202, ECO:0000269|PubMed:24286864}.;
- Pathway
- Metabolism of lipids;Fatty acyl-CoA biosynthesis;Metabolism;Fatty acid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- rvis_EVS
- -1.68
- rvis_percentile_EVS
- 2.63
Haploinsufficiency Scores
- pHI
- 0.416
- hipred
- Y
- hipred_score
- 0.626
- ghis
- 0.628
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.977
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Morc2a
- Phenotype
- homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; embryo phenotype;
Gene ontology
- Biological process
- fatty acid metabolic process
- Cellular component
- nucleus;cytosol
- Molecular function
- zinc ion binding